Disparities in Outcomes in Latino Subpopulations with Localized Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Analysis

<b>Objectives</b>: Prostate cancer is the most frequently diagnosed cancer among men, with Latino patients experiencing higher cancer-specific mortality compared to non-Hispanic populations. We evaluated prostate cancer outcomes across distinct Latino subpopulations. <b>Methods</b>: We retrospectively reviewed a single tertiary comprehensive cancer center database of patients with localized prostate cancer treated with radical prostatectomy from 2003 through 2020. Latino patients were subcategorized as Mexican, South/Central American (SCA), or Caribbean (Puerto Rico and Cuba). Non-Hispanic White (NHW) patients served as the reference group. <b>Results</b>: Overall, 7084 patients were included, of which 78% (<i>n</i> = 5518) were NHW and 10% (<i>n</i> = 679) were Latinos. Compared to NHW, Latino patients were younger at the time of surgery (median 62 vs. 64 years) and had higher median BMI (median 28.8 vs. 27.5 kg/m<sup>2</sup>), median baseline PSA (6.2 vs. 5.5 ng/mL), and D'Amico intermediate- (44% vs. 42%) and high-risk disease rates (16% vs. 13%) (all <i>p</i> < 0.001). Among Latino patients, Mexican patients had higher median baseline PSA (6.7 vs. 6.1 vs. 6.1 ng/mL, <i>p</i> = 0.005) compared to SCA and Caribbean patients. Survival analysis revealed shorter 5-year (97% vs. 99%) and 10-year (89% vs. 96%) overall survival (OS) rates in Mexican Latinos compared to non-Mexican Latinos (both <i>p</i> < 0.05). The 5-year (77% vs. 80% vs. 95%) and 10-year (63% vs. 65% vs. 86%) biochemical recurrence-free survival rates were shorter for Mexican patients compared to SCA and Caribbean patients. On multivariable analysis, SCA subpopulation status was associated with significantly better OS, and pathologic T stage > T2 was associated with worse biochemical recurrence-free survival. <b>Conclusions</b>: We identified significant differences in prostate cancer outcomes for different Latino subpopulations, underscoring the importance of population disaggregation in this ethnic group.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-03-23
DOI
https://doi.org/10.3390/cancers18061035
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Disparities in Outcomes in Latino Subpopulations with Localized Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Analysis

Oluwatimilehin Okunowo, Jonathan Yamzon, Wesley Yip, Daniel Lama et al.
Cancers
Prostate Cancer Diagnosis and Treatment
article

Disparities in Outcomes in Latino Subpopulations with Localized Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Analysis

Oluwatimilehin Okunowo, Jonathan Yamzon, Wesley Yip, Daniel Lama, Regina Barragán-Carrillo, Bertram Yuh, Ahmad Imam, Salvador Jaime-Casas, Abhishek Tripathi, Anjaney Kothari, Tanya Dorff, Kevin G. Chan, Alexander Chehrazi-Raffle, Ali Zhumkhawala, Sumanta K. Pal, Clayton S. Lau
article en

Abstract

<b>Objectives</b>: Prostate cancer is the most frequently diagnosed cancer among men, with Latino patients experiencing higher cancer-specific mortality compared to non-Hispanic populations. We evaluated prostate cancer outcomes across distinct Latino subpopulations. <b>Methods</b>: We retrospectively reviewed a single tertiary comprehensive cancer center database of patients with localized prostate cancer treated with radical prostatectomy from 2003 through 2020. Latino patients were subcategorized as Mexican, South/Central American (SCA), or Caribbean (Puerto Rico and Cuba). Non-Hispanic White (NHW) patients served as the reference group. <b>Results</b>: Overall, 7084 patients were included, of which 78% (<i>n</i> = 5518) were NHW and 10% (<i>n</i> = 679) were Latinos. Compared to NHW, Latino patients were younger at the time of surgery (median 62 vs. 64 years) and had higher median BMI (median 28.8 vs. 27.5 kg/m<sup>2</sup>), median baseline PSA (6.2 vs. 5.5 ng/mL), and D'Amico intermediate- (44% vs. 42%) and high-risk disease rates (16% vs. 13%) (all <i>p</i> < 0.001). Among Latino patients, Mexican patients had higher median baseline PSA (6.7 vs. 6.1 vs. 6.1 ng/mL, <i>p</i> = 0.005) compared to SCA and Caribbean patients. Survival analysis revealed shorter 5-year (97% vs. 99%) and 10-year (89% vs. 96%) overall survival (OS) rates in Mexican Latinos compared to non-Mexican Latinos (both <i>p</i> < 0.05). The 5-year (77% vs. 80% vs. 95%) and 10-year (63% vs. 65% vs. 86%) biochemical recurrence-free survival rates were shorter for Mexican patients compared to SCA and Caribbean patients. On multivariable analysis, SCA subpopulation status was associated with significantly better OS, and pathologic T stage > T2 was associated with worse biochemical recurrence-free survival. <b>Conclusions</b>: We identified significant differences in prostate cancer outcomes for different Latino subpopulations, underscoring the importance of population disaggregation in this ethnic group.

CancersVol. 18(6)
City Of Hope National Medical Center (US), City of Hope (US), Instituto Nacional de Cancerología (MX)
Good health and well-being
Openalex Percentile: Top 12%
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.